Urinary neutrophil gelatinase-associated lipocalin is a promising biomarker for late onset culture-positive sepsis in very low birth weight infants

Pediatric Research

Volumn 67, Issue 6, 2010, Pages 636-640

  Parravicini, Elvira ^a   Nemerofsky, Sheri L ^c   Michelson, Kenneth A ^b   Huynh, Trang K ^d   Sise, Meghan E ^b   Bateman, David A ^a   Lorenz, John M ^a   Barasch, Jonathan M ^b  

^a Department of Pediatrics ^*  (United States)

^b Columbia University ^*  (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ARTICLE; BACTERIUM CULTURE; BLOOD CULTURE; CANDIDA; CONTROLLED STUDY; DISEASE MARKER; EARLY DIAGNOSIS; FEMALE; GRAM NEGATIVE BACTERIUM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN SEPSIS; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TREATMENT DURATION; URINALYSIS; VERY LOW BIRTH WEIGHT;

ACUTE-PHASE PROTEINS; ANTI-BACTERIAL AGENTS; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, VERY LOW BIRTH WEIGHT; LIPOCALINS; MALE; NEW YORK CITY; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEPSIS; TIME FACTORS; TREATMENT OUTCOME; UP-REGULATION;

EID: 77952501093     PISSN: 00313998     EISSN: 15300447     Source Type: Journal    
DOI: 10.1203/PDR.0b013e3181da75c1     Document Type: Article

References (24)

1. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE, Oh W, Bauer CR, Korones SB, Shankaran S, Laptook AR, Stevenson DK, Papile LA, Poole WK 2002 Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 110:285-291
2. Bizzarro MJ, Raskind C, Baltimore RS, Gallagher PG 2005 Seventy-five years of neonatal sepsis at Yale:1928-2003. Pediatrics 116:595-602
3. Graham PL III, Begg MD, Larson E, Della-Latta P, Allen A, Saiman L 2006 Risk factors for late onset gram-negative sepsis in low birth weight infants hospitalized in the neonatal intensive care unit. Pediatr Infect Dis J 25:113-117
4. Fanaroff AA, Stoll BJ, Wright LL, Carlo WA, Ehrenkranz RA, Stark AR, Bauer CR, Donovan EF, Korones SB, Laptook AR, Lemons JA, Oh W, Papile LA, Shankaran S, Stevenson DK, Tyson JE, Poole WK; NICHD Neonatal Research Network 2007 Trends in neonatal morbidity and mortality for very low birthweight infants. Am J Obstet Gynecol 196:147.e1-e8
5. Brodie SB, Sands KE, Gray JE, Parker RA, Goldmann DA, Davis RB, Richardson DK 2000 Occurrence of nosocomial bloodstream infections in six neonatal intensive care units. Pediatr Infect Dis J 19:56-65
6. Apisarnthanarak A, Holzmann-Pazgal G, Hamvas A, Olsen MA, Fraser VJ 2004 Antimicrobial use and the influence of inadequate empiric antimicrobial therapy on the outcomes of nosocomial bloodstream infections in a neonatal intensive care unit. Infect Control Hosp Epidemiol 25:735-741
7. Rubin LG, Sánchez PJ, Siegel J, Levine G, Saiman L, Jarvis WR; Pediatric Prevention Network 2002 Evaluation and treatment of neonates with suspected late-onset sepsis: a survey of neonatologists' practices. Pediatrics 110:e42
8. Calil R, Marba ST, von Nowakonski A, Tresoldi AT 2001 Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Am J Infect Control 29:133-138
9. Benitz WE, Han MY, Madan A, Ramachandra P 1998 Serial serum C-reactive protein levels in the diagnosis of neonatal infection. Pediatrics 102:E41
10. Hengst JM 2003 The role of C-reactive protein in the evaluation and management of infants with suspected sepsis. Adv Neonatal Care 3:3-13
11. Ng PC, Lam HS 2006 Diagnostic markers for neonatal sepsis. Curr Opin Pediatr 18:125-131
12. Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P 2003 Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534-2543
13. Schmidt-Ott KM, Mori K, Kalandadze A, Li JY, Paragas N, Nicholas T, Devarajan P, Barasch J 2006 Neutrophil gelatinase-associated lipocalin-mediated iron traffic in kidney epithelia. Curr Opin Nephrol Hypertens 15:442-449
14. Schmidt-Ott KM, Mori K, Li JY, Kalandadze A, Cohen DJ, Devarajan P, Barasch J 2007 Dual action of neutrophil gelatinase-associated lipocalin. J Am Soc Nephrol 18:407-413
15. Mori K, Lee HT, Rapoport D, Drexler I, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Weiss S, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D'Agati V, Devarajan P, Barasch J 2005 Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury. J Clin Invest 115:610-621
16. Fjaertoft G, Foucard T, Xu S, Venge P 2005 Human neutrophil lipocalin (HNL) as a diagnostic tool in children with acute infections: a study of the kinetic. Acta Paediatr 94:661-666
17. Zappitelli M, Washburn KK, Arikan AA, Loftis L, Ma Q, Devarajan P, Parikh CR, Goldstein SL 2007 Urine neutrophil gelatinase-associated lipocalin as an early marker of acute kidney injury in critically ill children: a prospective cohort study. Crit Care 11:R84
18. Flo TH, Smith KD, Sato S, Rodriguez DJ, Holmes MA, Strong RK, Akira S, Aderem A 2004 Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432:917-921
19. Parravicini E, Lorenz JM, Nemerofsky SL, O'Rourke M, Barasch J, Bateman D 2009 Reference range of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants: preliminary data. Am J Perinatol 26:437-440
20. Huynh TK, Bateman DA, Parravicini E, Lorenz JM, Nemerofsky SL, Sise ME, Bowman TM, Polesana E, Barasch JM 2009 Reference values of urinary neutrophil gelatinase-associated lipocalin in very low birth weight infants. Pediatr Res 66:528-532
21. Yan L, Borregaard N, Kjeldsen L, Moses MA 2001 The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276:37258-37265
22. Cowland JB, Sørensen OE, Sehested M, Borregaard N 2003 Neutrophil gelatinase-associated lipocalin is up-regulated in human epithelial cells by IL-1 beta, but not by TNF-alpha. J Immunol 171:6630-6639
23. Nickolas TL, O'Rourke MJ, Yang J, Sise ME, Canetta PA, Barasch N, Buchen C, Khan F, Mori K, Giglio J, Devarajan P, Barasch JM 2008 Sensitivity and specificity of a single emergency department measurement of urinary neutrophil gelatinase-associated lipocalin for diagnosing acute kidney injury. Ann Intern Med 148:810-819
24. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL 2007 Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71:1028-1035